Delivery Order SPE2DB24D2205-SPE2DB25FEGJV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,330.50 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.60 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed price contract was competitively awarded without set-aside provisions and is scheduled for completion by August 28, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, will serve as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,641.31 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. This firm fixed-price, competitively awarded contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The vaccine will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ml syringe format, valued at $3,918.45 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,435.48 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe format (0.5mL). This non-set-aside contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a firm fixed-price delivery order. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a key distribution hub for the...
- The Defense Logistics Agency awarded a delivery order valued at $4,501.55 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine syringes (0.5mL) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,321.25 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in syringe format (0.5ML). This award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.75 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5 mL syringes. This competitive award, made on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed price delivery order with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in syringe form (0.5mL) valued at $1,863.95 under a firm fixed price contract. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025, and represents a non-set-aside competitive award. Performance of this delivery order will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $36,721.80 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This competitively awarded, firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's existing...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGJVDelivery Order
The Defense Logistics Agency awarded a $59,596.40 delivery order to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5ML syringes. Executed on August 18, 2025, with an ultimate completion date of August 19, 2025, this firm fixed-price contract represents a competitively awarded non-set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX contract), which extends through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare systems. The TDAP vaccine procurement supports immunization requirements across the Defense Health Agency and broader military healthcare infrastructure. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role as a primary vendor for pharmaceutical and medical supply distribution to military and veteran healthcare systems, with consistent delivery of vaccines, medications, and related medical commodities through competitively awarded delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $59.6k | 8/18/25 |